Recent News

• 08.19.2025 - Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
• 08.19.2025 - Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
• 08.14.2025 - Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
• 08.14.2025 - Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
• 08.14.2025 - Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity

Recent Filings

• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - 8-K Current report
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.15.2025 - 3/A Initial statement of beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4/A Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4/A Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities